|Bid||111.50 x 100|
|Ask||115.00 x 200|
|Day's Range||112.55 - 114.99|
|52 Week Range||81.12 - 121.75|
|PE Ratio (TTM)||37.97|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
BioTelemetry's (BEAT) buyout of LifeWatch AG has expanded its product portfolio and customer base in the cardiac monitoring and diagnostic services space.
Zacks.com featured highlights: SP Plus Corp, Edwards Lifesciences, Magna International and NVIDIA
Stryker's (SYK) diverse product portfolio alongside acquisition-driven strategy would continue to boost growth prospects. However, competition in the Chinese market raise concern.